Gilman Law LLP has filed a transvaginal mesh lawsuit on behalf of a woman from Missouri who suffered severe complications, including the need for two additional surgeries, following implantation of Johnson & Johnson's Gynecare Gynemesh transvaginal mesh device. The lawsuit, which was filed in U.S. District Court, District of New Jersey, names Johnson & Johnson, as well as its Ethicon Inc. unit among the Defendants. (Case No. ATL-L-5728-12)
Gilman Law LLP is offering free legal evaluations to all victims of transvaginal mesh complications. Consolidated litigations involving transvaginal mesh products marketed by Johnson & Johnson (MDL 2327), C.R. Bard (MDL 2187), American Medical Systems (MDL 2325), and Boston Scientific (MDL 2326) are currently pending in U.S. District Court, Southern District of West Virginia. C.R. Bard will face its first trial in that litigation, involving its Avaulta mesh product, on February 5, 2013. Women injured by transvaginal mesh are advised to seek legal counsel immediately to ensure their state's statute of limitations governing transvaginal mesh lawsuits does not expire. Once the statute of limitations has passed, transvaginal mesh victims will no longer be eligible to recover compensation from the manufacturers of these devices.
According to the lawsuit filed by Gilman Law LLP, the Gynemesh(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.